Today: 1 August 2025
27 January 2022
1 min read

Pfizer gets EU nod for Covid-19 pill

The EMA said it had evaluated data from a study involving patients with COVID-19, which showed that treatment with Paxlovid significantly reduced the risk of hospitalization…reports Asian Lite News

 The European Medicines Agency (EMA) has conditionally approved the use of US multinational biotechnology firm Pfizer’s Covid-19 pill for treating adults at risk of severe illness.

The endorsement allows the member states of the European Union (EU) to deploy the drug after the EMA gave guidance for its emergency use late in 2021, Xinhua news agency reported.

The EMA said in a statement that its Committee for Medicinal Products for Human Use (CHMP) had “recommended granting a conditional marketing authorization for the oral antiviral medicine Paxlovid for treating Covid-19 in adults who do not require supplemental oxygen and who are at increased risk of the disease becoming severe.”

Paxlovid is the first oral antiviral recommended in the EU for treating Covid-19. It consists of two active substances packaged together. One reduces the ability of SARS-CoV-2 to multiply in the body, while the other enables the first substance to remain longer in the body at levels that affect the multiplication of the virus.

The EMA said it had evaluated data from a study involving patients with COVID-19, which showed that treatment with Paxlovid significantly reduced the risk of hospitalization and death among patients with at least one underlying condition.

Most patients involved in the study were infected with the Delta variant of coronavirus. Based on laboratory studies, Paxlovid is also expected to be effective against Omicron and other variants, the EMA said, adding that the pill’s side effects were mild.

The EMA’s recommendation was sent to the European Commission for a rapid decision applicable in all EU member states.

ALSO READ: EU to sue China over Lithuania

Previous Story

Fake news about Nepal floods Chinese social media

Next Story

Nepal upset over China’s interference, Protests continue

Latest from -Top News

IBPC Dubai charts new growth path

Former Tata Motors CEO Ravi Kant headlines exclusive event as Indian business council sets course for transformation….reports Asian Lite News The Indian Business & Professional Council (IBPC) Dubai has signalled a significant

Miles in the Malls!

Dubai Mallathon kicks off today – The emirate’s biggest malls transform into indoor fitness arenas, inviting residents to walk, run, and win — all while staying cool, healthy, and community-connected….reports Asian Lite

Famine grips Gaza, WHO warns

WHO said Gaza’s population is facing acute food insecurity under the Integrated Food Security Phase Classification…reports Asian Lite News The World Health Organisation (WHO) has issued its starkest warning yet about the

Lifeline from UAE to Gaza

UAE’s Operation Chivalrous Knight 3 sustains Gaza’s collapsing health system with hospitals, treatment, aid, and vaccines, offering vital relief to thousands amid deepening crisis….reports Asian Lite News The United Arab Emirates has

Modi, MBZ talk big ties

The call reaffirmed their keenness to “strengthen relations in line with their shared vision to leverage opportunities and deepen strategic cooperation.”…reports Asian Lite News In a significant diplomatic engagement, Prime Minister Narendra
Go toTop

Don't Miss

EU chalks out 15bn-euro plan to tackle chip shortage

The EU aims to increase its global market share in

EU agrees massive Ukraine aid deal in ‘message’ to Putin

Zelenskyy noted, “It is very important that the decision was